Legislation


SB 326 (see companion bill HB 15) – Hawaii

Status: Inactive / Dead
Year Introduced: 2021
Link: https://www.capitol.hawaii.gov/measure_indiv.aspx?billtype=SB&billnumber=326&year=2022

Imposes dollar limits on specialty tiers in order to protect patients from unaffordable coinsurance or copayment amounts. Limits patients’ coinsurance or copayment fees for specialty tier drugs to $150 per month for up to a thirty-day period supply. Allow patients to request an exception to obtain a specialty drug that would not otherwise be available on a health plan formulary.


Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found